Strategy decision
Loading the recorded decision…
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Targets, reasoning, and execution evidence will appear here.
Strategy decision
Using this strategy in your portfolio? Open the Builder to review its source targets. Review your saved portfolio →
The decision
I retain the recent recorded allocation with only rounding-level adjustments to current holdings: 19% USD cash leaves an 81% non-cash budget. My base case favors continued large-cap leadership because QQQ and SPY returned 5.54% and 2.72% over 20 sessions, effective 2026-10-13. Negative small-cap, gold and Treasury trends argue against expanding those sleeves. The supplied evidence does not establish the growth, inflation or policy regime, so I avoid an unsupported macro rotation.
Targets & reasoning
Before is the portfolio weight captured at decision time. Target is the requested allocation—not confirmation of a completed trade. These are simulated strategy weights, not personalized allocations.
| Stock / cash | Before | Target | Change | Reason |
|---|---|---|---|---|
| QQQIncrease target | 25.85% | 26% | +0.15 pp | I expect QQQ to lead portfolio upside if growth-oriented leadership persists because its twenty-session return is 5.54% and its 743.57 close exceeds its 741.34 average.Hide full reasonI expect QQQ to lead portfolio upside if growth-oriented leadership persists because its twenty-session return is 5.54% and its 743.57 close exceeds its 741.34 average. I retain 26%, limiting dependence on this scenario. What would change the view: I'm wrong if sustained trend deterioration signals that leadership has failed. Original explanation and evidence referencesI expect QQQ to lead portfolio upside if growth-oriented leadership persists because its twenty-session return is 5.54% and its 743.57 close exceeds its 741.34 average [QQQ-E6] [QQQ-E3] [QQQ-E4]. I retain 26%, limiting dependence on this scenario. I'm wrong if sustained trend deterioration signals that leadership has failed. |
| SPYReduce target | 19.12% | 19% | -0.12 pp | I expect SPY to provide broad equity participation if the advance continues, supported by its 2.72% twenty-session return and 778.01 close above its 769.87 average.Hide full reasonI expect SPY to provide broad equity participation if the advance continues, supported by its 2.72% twenty-session return and 778.01 close above its 769.87 average. I retain 19% without adding aggregate equity risk. What would change the view: I'm wrong if a sustained reversal undermines the broader advance. Original explanation and evidence referencesI expect SPY to provide broad equity participation if the advance continues, supported by its 2.72% twenty-session return and 778.01 close above its 769.87 average [SPY-E5] [SPY-E3] [SPY-E4]. I retain 19% without adding aggregate equity risk. I'm wrong if a sustained reversal undermines the broader advance. |
| Cash · USDIncrease target | 18.95% | 19% | +0.05 pp | No holding-specific reason was recorded. |
| BILReduce target | 14.04% | 14% | -0.04 pp | I expect BIL to support patient redeployment because its 3.66% trailing dividend yield and 0.01% twenty-session return favor a stable liquidity part of the portfolio.Hide full reasonRecorded explanation · terminology clarified Conviction: medium · Horizon: monthsI expect BIL to support patient redeployment because its 3.66% trailing dividend yield and 0.01% twenty-session return favor a stable liquidity part of the portfolio. I retain 14% alongside USD cash rather than add duration. What would change the view: I'm wrong if price instability undermines its role or stronger opportunities justify redeployment. Original explanation and evidence referencesI expect BIL to support patient redeployment because its 3.66% trailing dividend yield and 0.01% twenty-session return favor a stable liquidity sleeve [BIL-E3] [BIL-E5]. I retain 14% alongside USD cash rather than add duration. I'm wrong if price instability undermines its role or stronger opportunities justify redeployment. |
| GLDIncrease target | 8.97% | 9% | +0.03 pp | I expect GLD to diversify outcomes if inflation uncertainty challenges both equities and Treasuries, but its negative 3.17% twenty-session return limits confidence.Hide full reasonI expect GLD to diversify outcomes if inflation uncertainty challenges both equities and Treasuries, but its negative 3.17% twenty-session return limits confidence. I retain a modest 9% rather than anticipate a confirmed reversal. What would change the view: I'm wrong if gold continues weakening when the portfolio needs protection from that scenario. Original explanation and evidence referencesI expect GLD to diversify outcomes if inflation uncertainty challenges both equities and Treasuries, but its negative 3.17% twenty-session return limits confidence [GLD-E4]. I retain a modest 9% rather than anticipate a confirmed reversal. I'm wrong if gold continues weakening when the portfolio needs protection from that scenario. |
| IWMReduce target | 7.03% | 7% | -0.03 pp | I expect IWM to contribute if equity participation broadens, but its 276.70 close below the 281.14 average and negative 2.96% twenty-session return leave that scenario unconfirmed.Hide full reasonI expect IWM to contribute if equity participation broadens, but its 276.70 close below the 281.14 average and negative 2.96% twenty-session return leave that scenario unconfirmed. I retain only 7% for conditional upside. What would change the view: I'm wrong if persistent weakness defeats the breadth-expansion thesis. Original explanation and evidence referencesI expect IWM to contribute if equity participation broadens, but its 276.70 close below the 281.14 average and negative 2.96% twenty-session return leave that scenario unconfirmed [IWM-E3] [IWM-E4] [IWM-E6]. I retain only 7% for conditional upside. I'm wrong if persistent weakness defeats the breadth-expansion thesis. |
| IEFReduce target | 6.04% | 6% | -0.04 pp | I expect IEF to contribute income and potential ballast if weaker growth supports Treasury demand, with a 4.15% trailing dividend yield.Hide full reasonI expect IEF to contribute income and potential ballast if weaker growth supports Treasury demand, with a 4.15% trailing dividend yield. Its negative 1.41% twenty-session return keeps duration exposure limited to 6%. What would change the view: I'm wrong if inflation pressure prevents bonds from cushioning an equity setback. Original explanation and evidence referencesI expect IEF to contribute income and potential ballast if weaker growth supports Treasury demand, with a 4.15% trailing dividend yield [IEF-E3]. Its negative 1.41% twenty-session return keeps duration exposure limited to 6% [IEF-E5]. I'm wrong if inflation pressure prevents bonds from cushioning an equity setback. |
Portfolio checks
The complete proposal passed the versioned universe, cash, concentration, and posture constraints without platform modification.
These checks cover portfolio constraints. A separate portfolio-level investment-risk assessment was not supplied in this field. Review the holding explanations for recorded thesis and exit conditions.
Ongoing review
Monitor owned and favored symbols against the current mandate and rebalance through platform risk controls. Monitor for mandate drift. Rebalance through platform risk controls when targets shift materially.
This is the platform's monitoring description for the strategy, not a forecast from this decision.
Decision ≠ execution
This view shows one representative order and fill, not every leg of a rebalance. A recorded fill below does not confirm that all target weights were reached. Open the strategy portfolio to inspect current holdings.
Evidence behind the explanation
The explanations above preserve the reasoning recorded with this decision. The record details below show processing and execution history. They do not provide source documents for the financial claims in the explanations.
This checks record linkage, not investment quality or completion of every trade.
These identify processing inputs and validation steps. They are not linked research sources.
Global Macro produced a canonical target-weight decision.
Global Macro cycle started by scheduled.
Global Macro cycle completed with status no_action; elapsedMs=30953.
Global Macro valuation snapshot recorded for agent_cycle_run 01M4X29JDTE0E5X3NG73RQWHD5.
